|

INV-1120 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • Shenzhen Ionova Life Sciences Co., Ltd.1

Indications

  • Cancer Metastatic1
  • Solid Tumor, Unspecified, Adult1
  • Tumor, Solid1
  • Solid Carcinoma1
  • Solid Tumor, Adult1

Lafayette, Indiana1 trial

An Open-Label Study of INV-1120 as a Single Agent and in Combination With Pembrolizumab in Adult Patients With Advanced Solid Tumors

Horizon Oncology Research, LLC,

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.